Supplementary Table 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Supplementary Table 2. Signature scores with significanlty changes pre- and post-Olaparib based treatment
创建时间：
2023-08-10
